Multimarker in normal colorectal mucosa to predict occurrence of colorectal neoplasm
Not Applicable
- Conditions
- Neoplasms
- Registration Number
- KCT0000553
- Lead Sponsor
- Asan Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Patients who underwent colonoscopy at our institution during the study period
Exclusion Criteria
1. Age <30 or >80
2. Familial adenomatous polyposis, Hereditary non-polyposis colorectal cancer
3. Inflammatory bowel disease
4. Prior history of previous colorectal resection
5. Coagulopathy (PT INR >1.5, platelet < 80,000/ml)
6. Anticoagulation therapy
7. Patients who can not discontinue antiplatelet agent(except aspirin) for 1 weeks before colonoscopy
8. Other severe diseases and acute disease (such as gastrointestinal bleeding, perforation or obstruction)
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Association of Mulkimarker expression pattern and synchronous neoplasm
- Secondary Outcome Measures
Name Time Method Association of Mulkimarker expression pattern and metachronous neoplasm